The incidence of mental illness was higher among women with MS during both the prenatal period (incidence ratio [IR] 1.26, 95 ...
MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, according to a ...
Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...
The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.